Corpus Intelligence IC Memo — ASCENSION BORGESS-LEE HOSPITAL 2026-04-26 15:58 UTC
IC Memo — ASCENSION BORGESS-LEE HOSPITAL
Investment Committee Memorandum | MI | 25 beds | Grade C | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ASCENSION BORGESS-LEE HOSPITAL

CCN 231315 | CASS, MI | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ASCENSION BORGESS-LEE HOSPITAL is a 25-bed under-performing / distressed in CASS, MI with $18.2M in net patient revenue and a -19.8% operating margin. The hospital serves a payer mix of 30.4% Medicare, 2.5% Medicaid, and 67.1% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -19.8% to -12.5% (+736bps).

Net Revenue HCRIS$18.2M
Current EBITDA COMPUTED$-3.6M
Operating Margin COMPUTED-19.8%
Occupancy HCRIS22.7%
Revenue / Bed COMPUTED$728K
Net-to-Gross HCRIS42.7%
Distress Probability ML56.0%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
72
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -19.8% places it below the state median. Among 72 size-comparable peers (12-50 beds), the median margin is -3.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 72 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ASCENSION BORGESS-LEE HOSPITAL (Target)MI25$18.2M-19.8%
TRINITY HEALTH LIVINGSTONMI42$200.4M15.2%
MYMICHIGAN MEDICAL CENTER ALMAMI49$142.2M-5.9%
SPECTRUM HEALTH UNITED MEMORIAMI45$129.4M9.7%
DICKINSON COUNTY HEALTHCARE SYMI49$126.3M-4.7%
MUNSON HEALTHCARE CADILLAC HOSMI49$122.7M1.0%
MCLAREN CENTRAL MICHIGANMI49$118.9M-35.3%
SPECTRUM HEALTH GERBERMI25$116.2M16.0%
SPECTRUM HEALTH LUDINGTONMI45$110.1M5.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$382K+210bp18mo
Cost to Collect4.5%2.5%$364K+200bp12mo
Denial Rate Reduction12.0%6.5%$360K+198bp12mo
A/R Days Reduction5200.0%3800.0%$222K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$382K
Cost to Collect
$364K
Denial Rate Reduction
$360K
A/R Days Reduction
$222K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.3M
Current EBITDA$-3.6M
+ RCM Uplift+$1.3M
Pro Forma EBITDA$-2.3M
Current Margin-19.8%
Pro Forma Margin-12.5%
WC Released (1x)$698K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.6M$-10.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.6M$-13.3M0.00x-100.0%
Bull Case9.0x11.0x$-5.0M$-10.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.0M$-13.1M0.00x-100.0%
Bear Case11.0x10.0x$-6.1M$-15.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-6.1M$-18.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 22.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 56.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 72 hospitals with 12-50 beds
  • Same-state prioritization (n=73)
  • Comp margins: P25=-10.9% / P50=-3.3% / P75=8.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.